Wesbanco Bank Inc. Buys Shares of 11,109 Prestige Consumer Healthcare Inc. (NYSE:PBH)

Wesbanco Bank Inc. purchased a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 11,109 shares of the company's stock, valued at approximately $806,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Vanguard Group Inc. boosted its position in Prestige Consumer Healthcare by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 5,756,138 shares of the company's stock worth $352,391,000 after purchasing an additional 63,375 shares in the last quarter. Ariel Investments LLC grew its stake in Prestige Consumer Healthcare by 173.8% in the 3rd quarter. Ariel Investments LLC now owns 2,534,786 shares of the company's stock valued at $144,964,000 after acquiring an additional 1,609,044 shares during the last quarter. Massachusetts Financial Services Co. MA increased its holdings in Prestige Consumer Healthcare by 0.8% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,101,504 shares of the company's stock valued at $62,995,000 after acquiring an additional 8,661 shares in the last quarter. Allspring Global Investments Holdings LLC increased its holdings in Prestige Consumer Healthcare by 19.1% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,087,821 shares of the company's stock valued at $62,213,000 after acquiring an additional 174,416 shares in the last quarter. Finally, Congress Asset Management Co. MA increased its holdings in Prestige Consumer Healthcare by 12.5% during the 1st quarter. Congress Asset Management Co. MA now owns 764,013 shares of the company's stock valued at $55,437,000 after acquiring an additional 84,757 shares in the last quarter. Institutional investors and hedge funds own 99.95% of the company's stock.

Prestige Consumer Healthcare Trading Down 1.8 %

Shares of NYSE PBH traded down $1.26 during midday trading on Friday, reaching $70.00. 223,436 shares of the stock were exchanged, compared to its average volume of 198,460. The company has a market capitalization of $3.48 billion, a P/E ratio of -42.68, a P/E/G ratio of 1.93 and a beta of 0.53. Prestige Consumer Healthcare Inc. has a 52-week low of $55.96 and a 52-week high of $75.31. The company has a current ratio of 3.09, a quick ratio of 1.92 and a debt-to-equity ratio of 0.75. The stock has a 50 day moving average price of $71.12 and a 200-day moving average price of $64.63.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings results on Thursday, February 8th. The company reported $1.06 EPS for the quarter, topping analysts' consensus estimates of $1.04 by $0.02. The business had revenue of $282.74 million during the quarter, compared to the consensus estimate of $280.25 million. Prestige Consumer Healthcare had a negative net margin of 7.11% and a positive return on equity of 14.09%. The company's quarterly revenue was up 2.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.04 earnings per share. Equities research analysts expect that Prestige Consumer Healthcare Inc. will post 4.33 earnings per share for the current fiscal year.

Insider Transactions at Prestige Consumer Healthcare

In other news, SVP Mary Beth Fritz sold 5,336 shares of Prestige Consumer Healthcare stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $69.00, for a total transaction of $368,184.00. Following the completion of the sale, the senior vice president now directly owns 15,934 shares in the company, valued at $1,099,446. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.60% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have weighed in on PBH. StockNews.com upgraded shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, February 10th. TheStreet upgraded shares of Prestige Consumer Healthcare from a "c+" rating to a "b-" rating in a report on Monday, February 12th. One equities research analyst has rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $110.00.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.